Literature DB >> 5053920

Treatment of previously intractable depressions with tranylcypromine and lithium.

J M Himmelhoch, T Detre, D J Kupfer, M Swartzburg, R Byck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5053920     DOI: 10.1097/00005053-197209000-00009

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  11 in total

Review 1.  Bipolar depression: management options.

Authors:  Gin S Malhi; Philip B Mitchell; Shahzad Salim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  The role of monoamine oxidase inhibitors in current psychiatric practice.

Authors:  Jess G Fiedorowicz; Karen L Swartz
Journal:  J Psychiatr Pract       Date:  2004-07       Impact factor: 1.325

Review 3.  Drug alternatives to lithium in manic-depressive disorders.

Authors:  D M Shaw
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

4.  Ethics of predictive testing for Huntington's chorea: the need for more information.

Authors:  D I Craufurd; R Harris
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-26

Review 5.  Review of clinically important drug interactions with lithium.

Authors:  N S Harvey; S Merriman
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 6.  Subtypes of depression--diagnosis and medical management.

Authors:  R J Bielski; R O Friedel
Journal:  West J Med       Date:  1977-05

Review 7.  Assessment and treatment of bipolar disorder in the elderly.

Authors:  J H Eastham; D V Jeste; R C Young
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

8.  The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.

Authors:  D G Grahame-Smith; A R Green
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739

9.  Effects of repeated lithium administration on the subcellular distribution of 5-hydroxytryptamine in rat brain.

Authors:  C K Atterwill; A F Tordoff
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

Review 10.  Risk-benefit assessment of newer versus older monoamine oxidase (MAO) inhibitors.

Authors:  Y Lecrubier
Journal:  Drug Saf       Date:  1994-04       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.